Skip to main content
SpringerLink
Log in

Suvorexant initiation reduces resource use and costs for insomnia patients in the USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2018 US dollars

Reference

  • Kale HP, et al. Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant. Advances in Therapy : 31 Aug 2021. Available from: URL: http://doi.org/10.1007/s12325-021-01891-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suvorexant initiation reduces resource use and costs for insomnia patients in the USA. PharmacoEcon Outcomes News 887, 27 (2021). https://doi.org/10.1007/s40274-021-08043-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08043-0

Search

Navigation